Artivion (AORT) Non Operating Interest Expenses (2010 - 2026)
Artivion's (AORT) quarterly Non Operating Interest Expenses came in at $7.3 million in Q2 2026, little changed on a YoY basis from $7.3 million in Q2 2025, and up 35.14% quarter-over-quarter from $5.4 million in Q1 2026.
Analysis
Artivion (AORT) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
Artivion (AORT) has reported Non Operating Interest Expenses for 17 consecutive years, with $7.3 million the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Non Operating Interest Expenses changed 0.23% year-over-year to $7.3 million; the trailing twelve-month figure through Jun 2026 stood at $24.3 million (down 26.64% YoY), and the FY2025 full-year result was $26.6 million, down 22.45% from the prior year.
- Non Operating Interest Expenses grew to $7.3 million in Q2 2026 per AORT's latest filing, from $5.4 million in the prior quarter.
- Across five years, Non Operating Interest Expenses topped out at $9.7 million in Q4 2024 and bottomed at $3.9 million in Q1 2022.
- Historically, Non Operating Interest Expenses has averaged $6.5 million across 5 years, with a median of $6.3 million in 2023.
- The sharpest annual moves came in 2024 and 2025: Non Operating Interest Expenses jumped 56.02% in 2024, then sank 43.24% in 2025.
- Over 5 years, Non Operating Interest Expenses stood at $5.4 million in 2022, then gained by 16.28% to $6.2 million in 2023, then surged by 56.02% to $9.7 million in 2024, then tumbled by 43.24% to $5.5 million in 2025, then soared by 31.16% to $7.3 million in 2026.
- According to Business Quant data, Non Operating Interest Expenses over the past three periods registered $7.3 million, $5.4 million, and $5.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 183.94 Bn | 178.34 Bn | 7.27 Bn | 351.00 Mn |
| 2 | Intuitive Surgical | 124.29 Bn | 119.08 Bn | 1.96 Bn | - |
| 3 | Medtronic | 118.22 Bn | 109.40 Bn | 6.34 Bn | 186.00 Mn |
| 4 | Stryker | 104.52 Bn | 101.04 Bn | 4.50 Bn | 141.00 Mn |
| 5 | Boston Scientific | 66.33 Bn | 65.79 Bn | 3.85 Bn | 96.00 Mn |
| 6 | Edwards Lifesciences | 49.61 Bn | 45.35 Bn | 1.35 Bn | - |
| 7 | Alcon | 33.94 Bn | 32.49 Bn | 1.68 Bn | -53.00 Mn |
| 8 | Dexcom | 32.18 Bn | 30.23 Bn | 830.00 Mn | - |
| 9 | Steris | 21.13 Bn | 20.65 Bn | 684.20 Mn | 15.80 Mn |
| 10 | Artivion | 1.23 Bn | 1.15 Bn | 80.52 Mn | 7.25 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 7.25 Mn |
| Mar 31, 2026 | 5.37 Mn |
| Dec 31, 2025 | 5.53 Mn |
| Sep 30, 2025 | 6.12 Mn |
| Jun 30, 2025 | 7.27 Mn |
| Mar 31, 2025 | 7.66 Mn |
| Dec 31, 2024 | 9.74 Mn |
| Sep 30, 2024 | 8.41 Mn |
| Jun 30, 2024 | 8.30 Mn |
| Mar 31, 2024 | 7.83 Mn |
| Dec 31, 2023 | 6.24 Mn |
| Sep 30, 2023 | 6.60 Mn |
| Jun 30, 2023 | 6.36 Mn |
| Mar 31, 2023 | 6.10 Mn |
| Dec 31, 2022 | 5.37 Mn |
| Sep 30, 2022 | 4.81 Mn |
| Jun 30, 2022 | 4.10 Mn |
| Mar 31, 2022 | 3.95 Mn |
| Dec 31, 2021 | 3.91 Mn |
| Sep 30, 2021 | 4.10 Mn |